KraneShares
KraneShares Cross-Lists KOID Humanoid Robotics ETF on Deutsche Börse Xetra Under Ticker KBOT
KraneShares Cross-Lists KOID Humanoid Robotics ETF on Deutsche Börse Xetra Under Ticker KBOT
FRANKFURT, Germany, Jan. 23, 2026 (GLOBE NEWSWIRE) -- KraneShares, a global asset manager known for its innovative exchange-traded funds (ETFs), announced the cross-listing of the KraneShares Global Humanoid & Embodied Intelligence Index UCITS ETF on Deutsche Börse Xetra, where it will trade under the ticker KBOT.
The Xetra listing brings to German investors the same globally recognized strategy known under the ticker KOID, which is already listed on Nasdaq, the London Stock Exchange, and Borsa Italiana. While the fund trades under the ticker KBOT in Germany, the ETF’s investment objective, index methodology, and underlying holdings are identical across all listings.
The KraneShares Global Humanoid & Embodied Intelligence Index UCITS ETF provides investors with targeted exposure to the rapidly expanding humanoid robotics and embodied intelligence ecosystem—an emerging industry at the intersection of robotics, artificial intelligence, and advanced manufacturing. The strategy offers a diversified portfolio of companies developing humanoid robots, as well as the critical enabling technologies behind them, including sensors, actuators, semiconductors, and the AI software that allows machines to perceive, learn, and interact with the physical world.
“We are pleased to bring our globally established humanoid and embodied intelligence strategy to Germany, one of the world’s most important markets for industrial automation and robotics innovation," said Dr. Xiaolin Chen, Head of International at KraneShares. "Germany’s leadership in manufacturing and automotive engineering positions it at the forefront of humanoid adoption, and the Xetra listing under KBOT provides German investors with a clear and efficient way to access this global growth theme.”
The ETF employs an equal-weight methodology, designed to deliver balanced exposure across the humanoid robotics value chain. Holdings include established global leaders such as Tesla and NVIDIA, alongside emerging innovators such as RoboSense, UBTECH, and Horizon Robotics. The portfolio also includes prominent German industrial and technology companies, including Infineon Technologies and Schaeffler, highlighting Germany’s integral role in automation and advanced manufacturing.
The listing comes as humanoid robots begin transitioning from research and pilot programs into real-world commercial deployment. Humanoids are increasingly being introduced across factories, logistics centers, healthcare settings, and service environments, helping address structural challenges such as labor shortages, aging populations, and workplace safety. Analysts, including Morgan Stanley, project that humanoids could number 1 billion units globally and generate up to $5 trillion in annual revenue by 2050, driven by adoption across multiple industries.¹
UCITS Exchange Listings
| Exchange | Ticker | Currency | Listing Date | SEDOL | ISIN |
| London Stock Exchange | KOIB LN | GBP | 09 Oct 2025 | BW5Y2M6 | IE000O6Z73N7 |
| London Stock Exchange | KOID LN | USD | 09 Oct 2025 | BLDCL51 | IE000O6Z73N7 |
| Borsa Italiana | KOID IM | EUR | 16 Oct 2025 | BVPW8S1 | IE000O6Z73N7 |
| Deutsche Börse Xetra | KBOT GY | EUR | 05 Jan 2026 | BPTJ8H5 | IE000O6Z73N7 |
For more information on the KraneShares Global Humanoid & Embodied Intelligence Index UCITS ETF (KBOT / KOID), please visit kraneshares.eu/etf/koidln or consult your financial advisor.
About KraneShares
KraneShares is a specialist investment manager focused on delivering global investors innovative, high-conviction strategies. The firm is known for its China and climate-focused ETFs, as well as its solutions across emerging markets, carbon allowances, options income, and disruptive technologies like artificial intelligence and electric vehicles. KraneShares helps investors access transformative growth opportunities through research-driven products and educational resources.
For standard performance, top 10 holdings, risks, and other fund information, please click here. Holdings are subject to change.
Citations:
- “Humanoids: 1bn Robots and $5tn Revenues by 2050, China is in Pole Position” Morgan Stanley Research, 28/Apr/2025.
Carefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds' full and summary prospectus, which may be obtained by visiting https://www.kraneshares.eu/koidln. Read the prospectus carefully before investing.
Contact:
KraneShares Investor Relations
info@kraneshares.com

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alveus Therapeutics Inc23.1.2026 13:30:00 CET | Press release
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
LOWRISC C.I.C.23.1.2026 13:28:00 CET | Press release
OpenTitan Introduces New Membership Tiers and Deliverables to Accelerate Deployment
Investeringsforeningen C Worldwide23.1.2026 13:20:27 CET | Pressemeddelelse
Opdatering af forventede udbytter for regnskabsåret 2025
Plug Power, Inc.23.1.2026 13:00:00 CET | Press release
Plug Power Completes Installation of 100 MW GenEco Electrolyzer Units at Galp’s Sines Refinery
OKYO Pharma LTD23.1.2026 13:00:00 CET | Press release
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom